Status:
TERMINATED
Ultrasound Elastography to Predict Development of SOS
Lead Sponsor:
Children's Mercy Hospital Kansas City
Conditions:
Bone Marrow Transplant Complications
Sinusoidal Obstruction Syndrome
Eligibility:
All Genders
1-21 years
Phase:
NA
Brief Summary
The long-term goal of our research is to accurately identify SOS patients who would benefit from defibrotide treatment using US SWE. The overall objective of this study is to validate SWE as an early ...
Detailed Description
Hepatic sinusoidal obstructive syndrome (SOS) is a complication of blood and marrow transplant (BMT) that is associated with high morbidity and mortality. 57,000 patients in the United States and Euro...
Eligibility Criteria
Inclusion
- Children and adults, ages 1 month through 21 years who are undergoing allogenic or autologous myeloablative stem cell transplant.
Exclusion
- Any other medical or social condition that in the opinion of the investigator would make them unsuitable to participate.
- Inability to properly image patient by ultrasound (e.g. uncooperative)
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 16 2024
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03858530
Start Date
May 1 2018
End Date
January 16 2024
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Mercy Hospital
Kansas City, Missouri, United States, 64108